BioHealth News Archive
Symbiomix Therapeutics Studies Show Drug Candidate for Women’s Health Infections is Safe and Well-Tolerated – kcentv.com – KCEN HD – Waco, Temple, and Killeen
Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical…
Read MoreAstraZeneca acquires rights to Actavis’ lung drugs – Pharmaceutical Business Review
AstraZeneca has completed the acquisition of Actavis’ branded respiratory business in the US and Canada for an initial consideration of $600m. The deal strengthens…
Read MoreOpGen Inc. of Gaithersburg files to raise up to $37 million in initial public offering – Washington Business Journal
Gaithersburg-based molecular diagnostics company OpGen Inc. filed Tuesday to go public in hopes of raising as much as $37.4 million. In its initial regulatory…
Read MoreInvestMaryland Challenge advances 46 companies – MDBIZNews
This spring, the InvestMaryland Challenge will award four $100,000 grand prizes to innovative young companies with the potential to flourish in Maryland. Now in its…
Read MoreLeidos Joins JHU Montgomery County Campus
The Johns Hopkins University Montgomery County Campus welcomes Leidos to the campus community. Leidos has located some of its employees in Building III, putting…
Read MoreMIKULSKI ANNOUNCES 5th TERM WILL BE HER LAST, WILL FOCUS ON WORKING FOR HER CONSTITUENTS
Today at Henderson’s Wharf Inn in Fells Point, U.S. Senator Barbara A. Mikulski (D-Md.) announced she has decided not to run for re-election. Senator…
Read MoreNEA leads $35 mln round for Mersana – PE HUB
Cambridge, Massachusetts-based Mersana Therapeutics Inc, a provider of Fleximer antibody-drug conjugate technology, has secured $35 million in Series B-1 financing. New Enterprise Associates led…
Read MoreMikulski, a role model for generations of women in politics, to retire in 2016 – The Washington Post
Sen. Barbara A. Mikulski, the Maryland Democrat who is the longest-serving woman in congressional history, will depart Capitol Hill the way she arrived —…
Read MoreWhy we should all be thrilled about the FDA starting to embrace innovation – The Washington Post
On Feb. 19, the U.S. Food and Drug Administration took a huge step towards patient-centric medicine when it approved the marketing of genetics testing…
Read MoreThese five health systems are making the best use of telemedicine
There’s been a flurry of news related to telemedicine this week, with several notable developments in Mississippi and Silicon Valley. One of the more…
Read MoreSBA Administrator Maria Contreras-Sweet: Baltimore reminds me of Detroit – Baltimore Business Journal
U.S. Small Business Administration leader Maria Contreras-Sweet drew parallels Friday between Baltimore and the rust-belt city of Detroit — but she actually meant it…
Read MoreA Recipe For Life Sciences Commercialization
As the landscape of the biopharmaceutical industry expands into growing regions, an exciting transformation is beginning to transfer commercialization “recipes” to emerging markets. All…
Read MoreUseful Stats: Share of U.S. Venture Capital Investment by State, 2009-2014 – SSTI
California-based companies received about 56 percent of all U.S. venture capital dollars in 2014, the state's highest share of venture activity since the dot…
Read MoreAngel investors want a state tax credit, even after tough questions – Baltimore Business Journal
Paul Palmieri thinks Maryland's entrepreneurs and innovators need a boost — especially after supporters of a state angel investor tax credit turned out in…
Read MoreQIAGEN Collaborates With Allele Frequency Community to Advance Translational Medicine and Clinical Diagnostics
A coalition of 13 leading life science and diagnostics organizations today announced the formation of the Allele Frequency Community, a landmark initiative that is…
Read More